Advanced or metastatic esophageal cancer (EC) is associated with poor prognosis, necessitating new and effective treatment methods. We assess whether claudin 6 (CLDN6) is a useful target for the ...
Genomic alterations are common in metastatic castration-resistant prostate cancer (mCRPC), but limited data exist on the response to 177Lu-PSMA-617 (LuPSMA) in patients with these aberrations. We ...
Quantitative analysis has been applied extensively to image processing and interpretation in nuclear cardiology to improve disease diagnosis and risk stratification. This is Part 2 of a two-part ...
Update to “Renal and Multiorgan Safety of 177 Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy” ...
Objectives The aim of our study was to compare two methods for SUVr calculations in amyloid PET brain imaging. Methods In a continuing study, 19 patients were imaged on a GE STE 16 slice PET/CT system ...
Journal of Nuclear Medicine April 2026, jnumed.125.271421; DOI: https://doi.org/10.2967/jnumed.125.271421 ...
Journal of Nuclear Medicine May 2026, jnumed.125.271564; DOI: https://doi.org/10.2967/jnumed.125.271564 ...
Most patients with idiopathic REM sleep behavior disorder (iRBD) will develop Parkinson disease (PD) or dementia with Lewy bodies (DLB) on long-term clinical follow-up (1–6). In such patients, REM ...
PET plays a key role in diagnosis and evaluation of medical conditions. Since 1998, when the first hybrid PET/CT system became operational (1), advances in PET technology have been significant. The ...
Journal of Nuclear Medicine April 2026, jnumed.125.271604; DOI: https://doi.org/10.2967/jnumed.125.271604 ...
Journal of Nuclear Medicine February 2026, jnumed.125.270494; DOI: https://doi.org/10.2967/jnumed.125.270494 ...
Journal of Nuclear Medicine March 2025, jnumed.124.269299; DOI: https://doi.org/10.2967/jnumed.124.269299 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results